Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival (Q34048270)
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival |
scientific article |
Statements
1 reference
Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival (English)
1 reference
Jedd D Wolchok
1 reference
Katherine S Panageas
1 reference
Jianda Yuan
1 reference
David B Page
1 reference
Sebastian E A Schroeder
1 reference
Richard D Carvajal
1 reference
Paul B Chapman
1 reference
Gary K Schwartz
1 reference
1 April 2010
1 reference
1 reference
116
1 reference
1767-1775
1 reference
Identifiers
1 reference
1 reference
1 reference